Blueprint Medicines Corp reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Blueprint Medicines Corp has filed 1,025 SEC EDGAR filings since 17 Jan 2014

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 426-450 of 1,000 matching filings.

Per page

25

Current page

18

4

FORM 4 -

Filing date: 17 Nov 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37359

FORM 8-K

Filing date: 09 Nov 2021
Reporting date: 08 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 -

Filing date: 05 Nov 2021
Reporting date: 03 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-37359

10-Q

Filing date: 28 Oct 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37359

FORM 8-K

Filing date: 28 Oct 2021
Reporting date: 28 Oct 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 -

Filing date: 19 Oct 2021
Reporting date: 15 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 07 Oct 2021
Reporting date: 05 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 27 Sep 2021
Reporting date: 23 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 27 Sep 2021
Reporting date: 23 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 27 Sep 2021
Reporting date: 23 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 17 Sep 2021
Reporting date: 15 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 17 Sep 2021
Reporting date: 02 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 15 Sep 2021
Reporting date: 13 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 15 Sep 2021
Reporting date: 13 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 30 Aug 2021
Reporting date: 26 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 23 Aug 2021
Reporting date: 19 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 19 Aug 2021
Reporting date: 17 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-37359

10-Q

Filing date: 29 Jul 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37359

8-K

Filing date: 29 Jul 2021
Reporting date: 29 Jul 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37359

8-K

Filing date: 28 Jul 2021
Reporting date: 28 Jul 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CT ORDER File 001-37359

CT ORDER filing

Filing date: 01 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 30 Jun 2021
Reporting date: 28 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37359

FORM 8-K

Filing date: 16 Jun 2021
Reporting date: 16 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .